Abstract
The reprogramming of differentiated cells into induced pluripotent stem cells (iPSCs) is usually achieved by exogenous induction of transcription by factors acting in the nucleus. In contrast, during development, signaling pathways initiated at the membrane induce differentiation. The central idea of this study is to identify antibodies that can catalyze cellular de-differentiation and nuclear reprogramming by acting at the cell surface. We screen a lentiviral library encoding ∼100 million secreted and membrane-bound single-chain antibodies and identify antibodies that can replace either Sox2 and Myc (c-Myc) or Oct4 during reprogramming of mouse embryonic fibroblasts into iPSCs. We show that one Sox2-replacing antibody antagonizes the membrane-associated protein Basp1, thereby de-repressing nuclear factors WT1, Esrrb and Lin28a (Lin28) independent of Sox2. By manipulating this pathway, we identify three methods to generate iPSCs. Our results establish unbiased selection from autocrine combinatorial antibody libraries as a robust method to discover new biologics and uncover membrane-to-nucleus signaling pathways that regulate pluripotency and cell fate.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Boland, M.J. et al. Adult mice generated from induced pluripotent stem cells. Nature 461, 91–94 (2009).
Kang, L., Wang, J., Zhang, Y., Kou, Z. & Gao, S. iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell 5, 135–138 (2009).
Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).
Zhao, X.Y. et al. iPS cells produce viable mice through tetraploid complementation. Nature 461, 86–90 (2009).
Ieda, M. et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375–386 (2010).
Jopling, C., Boue, S. & Izpisua Belmonte, J.C. Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration. Nat. Rev. Mol. Cell Biol. 12, 79–89 (2011).
Tsunemoto, R.K., Eade, K.T., Blanchard, J.W. & Baldwin, K.K. Forward engineering neuronal diversity using direct reprogramming. EMBO J. 34, 1445–1455 (2015).
Vierbuchen, T. et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463, 1035–1041 (2010).
Arkin, M.R., Tang, Y. & Wells, J.A. Small-molecule inhibitors of protein-protein interactions: progressing toward the reality. Chem. Biol. 21, 1102–1114 (2014).
Laraia, L., McKenzie, G., Spring, D.R., Venkitaraman, A.R. & Huggins, D.J. Overcoming chemical, biological, and computational challenges in the development of inhibitors targeting protein-protein interactions. Chem. Biol. 22, 689–703 (2015).
Carey, B.W. et al. Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell 9, 588–598 (2011).
Hanna, J. et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462, 595–601 (2009).
Stadtfeld, M., Maherali, N., Borkent, M. & Hochedlinger, K. A reprogrammable mouse strain from gene-targeted embryonic stem cells. Nat. Methods 7, 53–55 (2010).
Ichida, J.K. et al. A small-molecule inhibitor of TGF-β signaling replaces sox2 in reprogramming by inducing NANOG. Cell Stem Cell 5, 491–503 (2009).
Lyssiotis, C.A. et al. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc. Natl. Acad. Sci. USA 106, 8912–8917 (2009).
Staerk, J. et al. Pan-Src family kinase inhibitors replace Sox2 during the direct reprogramming of somatic cells. Angew. Chem. Int. Ed. 50, 5734–5736 (2011).
Qin, H. et al. Systematic identification of barriers to human iPSC generation. Cell 158, 449–461 (2014).
Borkent, M. et al. A serial shRNA screen for roadblocks to reprogramming identifies the protein modifier SUMO2. Stem Cell Rep. 6, 704–716 (2016).
Melidoni, A.N., Dyson, M.R., Wormald, S. & McCafferty, J. Selecting antagonistic antibodies that control differentiation through inducible expression in embryonic stem cells. Proc. Natl. Acad. Sci. USA 110, 17802–17807 (2013).
Xie, J., Zhang, H., Yea, K. & Lerner, R.A. Autocrine signaling based selection of combinatorial antibodies that transdifferentiate human stem cells. Proc. Natl. Acad. Sci. USA 110, 8099–8104 (2013).
Zhang, H., Wilson, I.A. & Lerner, R.A. Selection of antibodies that regulate phenotype from intracellular combinatorial antibody libraries. Proc. Natl. Acad. Sci. USA 109, 15728–15733 (2012).
Zhang, H. et al. Selecting agonists from single cells infected with combinatorial antibody libraries. Chem. Biol. 20, 734–741 (2013).
Zhang, H., Xie, J. & Lerner, R.A. A proximity based general method for identification of ligand and receptor interactions in living cells. Biochem. Biophys. Res. Commun. 454, 251–255 (2014).
Liu, T. et al. Construction and screening of a lentiviral secretome library. Cell Chem. Biol. 24, 767–771.e3 (2017).
Stadtfeld, M., Maherali, N., Breault, D.T. & Hochedlinger, K. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2, 230–240 (2008).
Hou, P. et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341, 651–654 (2013).
Radzisheuskaya, A. & Silva, J.C. Do all roads lead to Oct4? the emerging concepts of induced pluripotency. Trends Cell Biol. 24, 275–284 (2014).
Hazen, J.L. et al. The complete genome sequences, unique mutational spectra, and developmental potency of adult neurons revealed by cloning. Neuron 89, 1223–1236 (2016).
Maherali, N. & Hochedlinger, K. Tgfbeta signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Curr. Biol. 19, 1718–1723 (2009).
Shu, J. et al. Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell 153, 963–975 (2013).
Korshunova, I. et al. Characterization of BASP1-mediated neurite outgrowth. J. Neurosci. Res. 86, 2201–2213 (2008).
Maekawa, S., Maekawa, M., Hattori, S. & Nakamura, S. Purification and molecular cloning of a novel acidic calmodulin binding protein from rat brain. J. Biol. Chem. 268, 13703–13709 (1993).
Mosevitsky, M.I. et al. The BASP1 family of myristoylated proteins abundant in axonal termini. Primary structure analysis and physico-chemical properties. Biochimie 79, 373–384 (1997).
Hu, X. et al. Tet and TDG mediate DNA demethylation essential for mesenchymal-to-epithelial transition in somatic cell reprogramming. Cell Stem Cell 14, 512–522 (2014).
Li, R. et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 7, 51–63 (2010).
Carpenter, B. et al. BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1. Mol. Cell. Biol. 24, 537–549 (2004).
Toska, E. et al. Repression of transcription by WT1-BASP1 requires the myristoylation of BASP1 and the PIP2-dependent recruitment of histone deacetylase. Cell Rep. 2, 462–469 (2012).
Huang, S. Reprogramming cell fates: reconciling rarity with robustness. BioEssays 31, 546–560 (2009).
Buganim, Y. et al. Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 150, 1209–1222 (2012).
Buganim, Y. et al. The developmental potential of iPSCs is greatly influenced by reprogramming factor selection. Cell Stem Cell 15, 295–309 (2014).
Feng, B. et al. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat. Cell Biol. 11, 197–203 (2009).
Motamedi, F.J. et al. WT1 controls antagonistic FGF and BMP-pSMAD pathways in early renal progenitors. Nat. Commun. 5, 4444 (2014).
Melidoni, A.N., Dyson, M.R. & McCafferty, J. Selection of antibodies interfering with cell surface receptor signaling using embryonic stem cell differentiation. Methods Mol. Biol. 1341, 111–132 (2015).
Schlaeger, T.M. et al. A comparison of non-integrating reprogramming methods. Nat. Biotechnol. 33, 58–63 (2015).
Imai, K. & Takaoka, A. Comparing antibody and small-molecule therapies for cancer. Nat. Rev. Cancer 6, 714–727 (2006).
Blanchard, J.W. et al. Selective conversion of fibroblasts into peripheral sensory neurons. Nat. Neurosci. 18, 25–35 (2015).
Bolger, A.M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 (2014).
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
Anders, S., Pyl, P.T. & Huber, W. HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166–169 (2015).
Love, M.I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
Acknowledgements
We would like to thank J. Gottesfeld, A. Patapoutian, V. Lo Sardo and J. Hazen for assistance and/or helpful discussions; W. Ferguson for technical assistance and K. Spencer for assistance with microscopy. This research was supported by the National Institute on Deafness and other Communication Disorders (DC012592 to K.K.B.), the National Institute of Mental Health (MH102698 to K.K.B.), the California Institute for Regenerative Medicine (RB3-02186 to K.K.B.), the Baxter Family, Norris and Del Webb Foundations (K.K.B.), Las Patronas and the Dorris Neuroscience Center (K.K.B.), a predoctoral fellowship from the California Institute of Regenerative Medicine (J.W.B.) the Andrea Elizabeth Vogt Memorial Award (J.W.B.).
Author information
Authors and Affiliations
Contributions
Experiments were initially conceived by R.A.L. and K.K.B. Subsequent experimental design was contributed by all authors, and experiments were designed, performed and analyzed by J.W.B. and J.X. Experiments were also performed by S.L., S.G. and N.E.-M. The manuscript was written and revised by J.W.B., J.X. and K.K.B.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Integrated supplementary information
Supplementary Figure 1 Schematic and results of screening the combinatorial antibody library for Sox2 replacement activity.
A single batch of MEFs were plated and transduced with doxycycline inducible lentiviruses and an rTTA virus. Viral expression was induced for 14 days and images were collected. All MEFs were transduced with viruses encoding Oct4, Klf4 and a previously validated shRNA against p53 (shp53). Additional conditions included the positive control (left panel, with viruses encoding Sox2 and c-Myc), the test for the antibody library (middle panel, since we observed only a few colonies per plate, representative cut outs of colonies are shown) and a negative control with a lentivirus expressing tdTomato (red). Scale bars = 100 μm. Individual colonies arising in the screen were photographed at the same magnification as the other panels but cropped and enlarged variously for visual clarity.
Supplementary Figure 2 Validation of SoxAb- and OctAb-generated iPSCs.
Fig. S2 a and b) Antibody gene sequences were recovered by PCR performed on genomic DNA from iPSC lines. Primer binding sites are depicted in Fig. S1b as “recovery primers”. The amplicons were purified by gel extraction and sub-cloned into lentiviral or other expression vectors and submitted for sequencing. c) Primary colonies induced by Sox2 antibodies were capable of expanding into cell lines maintained under standard mouse ES conditions for at least ten passages. d) Primary colonies induced by Oct4 antibodies can be expanded into cell lines and maintained under standard mouse ES cell conditions for at least ten passages. e) iPSC lines generated with SoxAb2 do not harbor transgenic Sox2 or cMyc. f) iPSC lines generated with OctAb1 and 2 do not harbor transgenic Oct4, but do harbor transgenic human IgG. g) iPSC lines generated with SoxAb2 and OctAb1 express pluripotency markers SSEA1, Sox2, Oct3/4, and Nanog. Scale bars = 100 μm. h) iPS cell lines generated with OctAb2 and SoxAb2 differentiate in vitro to the three embryonic germ layers. Scale bars = 100 μm. i) iPSC lines generated with SoxAb1 differentiate in vivo and contribute to chimeric offspring. Eight-week old chimeric mice formed by injection of KO + SoxAb1 cells (CD1 genetic background) into a C57BL6 blastocyst. j) Chimeric pups display contribution of antibody iPSCs across three embryonic germ layers. k) Quantitative RT-PCR confirmation of the expression of pluripotency genes in the SoxAb1 and SoxAb2 iPSC lines, fully pluripotent iPSCs (iMZ-9 and iiMZ-21) and mESCs (V6.5) compared to control fibroblasts expressing OKM for twelve days under identical culture conditions used to derive the iPSCs. Bars represent the mean of two biological replicates, meaning independent wells of the cell line indicated. Error bars = SEM. l) RNA-seq scatter plots show that global gene expression of antibody-derived iPSC lines is highly similar to TEC competent iPSC (iMZ21) and mESC (MCNT) lines but different from somatic MEFs. Gene expression is plotted as vsd-normalized counts. m) Summary of differential expression analysis (using DESeq2) showing the number of genes that are significantly upregulated (red) and downregulated (blue), that exhibit a greater than 2-fold change in expression in MEFs, and antibody-iPSC lines compared to TEC-competent iPSCs and ESCs.
Supplementary Figure 3 Mechanisms governing reprogramming with SoxAb2 involve Basp1 inhibition.
a) SoxAb2 does not inhibit Tgf-β induced phosphorylation of Smad2/3 whereas small molecule inhibitors RepSox and Tgf-β neutralizing antibodies previously reported to promote Sox2-independent reprogramming do inhibit Tgf-β induced phosphorylation of Smad2/3. For each treatment (SoxAb2, RepSox, SB431542, and Tgf-β neutralizing antibodies) ability to inhibit Smad2/3 phosphorylation was quantified from three independent western blots. The graph depicts the mean from the three blots. Error bars represent SEM. Significance was determined by ANOVA followed by Newman-Keuls post-hoc analysis, *p<0.05, ** p<0.01. b) SoxAb2 does not directly inhibit Src-kinase activity. SoxAb2 ability to inhibit Src-kinase activity was compared to the small molecule PP1 a known Src-kinase inhibitor able to promote Sox2-independent reprogramming. c) SoxAb2 does not antagonize the induction of mesoderm genes. Mesoderm genes Eomes, T, and Ctnnb1 were quantified in three biological replicates of MEFs expressing Klf4 and Oct4 by RT-PCR following 96 hours expression of SoxAb2. Significance was assessed by ANOVA; no significant differences were observed. d) Proteins were immunoprecipitated with SoxAb2 separated by SDS-PAGE and stained with Coomassie brilliant blue. A ~25 KDa based was excised from control (middle) and SoxAb2-expressing (right) lanes and analyzed by trypsin digestion and mass spectrometry which identified candidate proteins enriched in each sample. e) SoxAb2 immunoprecipitates endogenous Basp1. MEFs were transduced with Basp1 (lanes 1,2) or not transduced (lane3). Lysates were immunoprecipitated with SoxAb2 (lanes 2 and 3) and Western blots were performed with either Anti-Basp1 (top) or the SoxAb2 (bottom). Basp1 protein was present and detected by both antibodies in the whole lysate from MEFs overexpressing Basp1 and enriched in pull-downs with the SoxAb2, demonstrating that the SoxAb2 recognized Basp1 protein. f) Quantitative RT-PCR confirming Basp1 shRNA significantly reduces Basp1 expression in MEFs; p=.0000084, Students T-Test. g) The changes in gene expression in MEFs directed by SoxAb2 or knockdown of Basp1 are strongly correlated. Heat map and hierarchical clustering of control MEFs compared to MEFs expressing SoxAb2 or Basp1 shRNA. Clustering represents single linkage Euclidian distance. h) Heat map and hierarchical clustering in MEFs expressing Klf4, Oct4, and cMyc (KOM) compared to KOM MEFs expressing SoxAb2 or Basp1 shRNA. Clustering represents single linkage Euclidian distance. i) Primary colonies induced by Basp1 knockdown + KOM can be expanded into cell lines and cultured under standard mES conditions for at least ten passages. j) Basp1 knockdown iPSC lines do not harbor transgenic viral Sox2 as expected but do harbor viral Oct4 and Klf4 genes. k) RNAseq scatter plots showing that global gene expression of Basp1 knockdown iPSC lines is highly divergent from somatic MEFs relative to iPSCs and mESCs. Gene expression is plotted as vsd-normalized counts.
Supplementary Figure 4 Downstream pathways related to Basp1 inhibition can replace Sox2 in generating iPSCs.
Panel a) Wt1 was co-immunoprecipitated with Basp1 in somatic MEFs. b) Primary colonies induced by Wt1 overexpression + KOM can be expanded into cell lines and cultured under standard mES conditions for at least ten passages. c) Wt1 overexpression + KOM iPSC lines appropriately express pluripotency marker SSEA1, Sox2, Oct4, and Nanog. d and e) RNAseq scatter plots showing global gene expression of KOM + Wt1 iPSC lines are highly similar to TEC competent iPSC (iMZ21) and mESC (MCNT) lines relative to their dissimilarity with somatic MEFs. Gene expression is plotted as vsd-normalized counts. f) Wt1 overexpression + KOM iPSC lines differentiate to the three embryonic germ layers in vitro. g) Scatter plots depicting mean changes in gene expression induced by Wt1 overexpression and Basp1 knockdown on day four and twelve of reprogramming. Expression is normalized to KOM only samples. Error bars = SEM. h) iPSC lines generated with Lin28/Esrrb + Klf4 and Oct4 express pluripotency markers SSEA1, Sox2, Oct4, and Nanog. i) Quantitative RT-PCR showing shRNA-mediated knockdown of Wt1 in iPSC line iMZ9 iPSC and v6.5 mESC reduces expression of Esrrb, Lin28, and the downstream target cMyc. Bars represent means from three biological replicates meaning independent wells of cells treated with the shRNA and analyzed separately. Error bars = SEM. Significance was tested by Students t-test for each comparison, * p<0.05, **p<0.01.
Supplementary Figure 5 Evidence that WT1 can bind to candidate Lin28 promoter regions.
WT1 ChIP-qRT-PCR on LIN28A and B genomic regions. Genomic PCR was performed on regions identified to contain WT1 consensus DNA-binding elements (green line) from in silico analysis. Bars represent the mean of three biologic replicates. Statistical significance was assessed by ANOVA, * p<0.05, **p<0.01. b) Expression of LIN28 (A and B), WT1 (C and D), and BASP1 (E and F) in CML patients. In the left panels, each bar represents a single patient. Right panels are averages of all patients for each group, with significance determined by ANOVA, ***p<0.001.
Supplementary Figure 6 Validation of shRNAs used in the study.
The shRNAs used in the study reduce expression of the expected proteins a) WT-1 protein level in MEF was reduced by three different shRNA sequences (Sigma Mission®), while the housekeeping gene actin is unaffected. b) BASP-1 protein level in MEF cells was reduced by two different shRNA sequences (Sigma Mission®) separately and in combination.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–7 (PDF 1849 kb)
Rights and permissions
About this article
Cite this article
Blanchard, J., Xie, J., El-Mecharrafie, N. et al. Replacing reprogramming factors with antibodies selected from combinatorial antibody libraries. Nat Biotechnol 35, 960–968 (2017). https://doi.org/10.1038/nbt.3963
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3963
This article is cited by
-
The Information Theory of Aging
Nature Aging (2023)
-
Selection of a picomolar antibody that targets CXCR2-mediated neutrophil activation and alleviates EAE symptoms
Nature Communications (2021)
-
Optogenetic regulation of endogenous proteins
Nature Communications (2020)
-
PBX homeobox 1 enhances hair follicle mesenchymal stem cell proliferation and reprogramming through activation of the AKT/glycogen synthase kinase signaling pathway and suppression of apoptosis
Stem Cell Research & Therapy (2019)
-
Human germ cell tumours from a developmental perspective
Nature Reviews Cancer (2019)